Skip to main content

Published locations for Ibrutinib proves active in high-risk CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib proves active in high-risk CLL

User login

  • Reset your password
  • /content/ibrutinib-proves-active-high-risk-cll
  • /hematology-oncology/article/188245/leukemia-myelodysplasia-transplantation/ibrutinib-proves-active-high-risk
  • /hematologytimes/article/188245/leukemia-myelodysplasia-transplantation/ibrutinib-proves-active-high